Bariatric Surgery vs. Semaglutide: A Study on Weight Loss Effectiveness

A new study from NYU indicates that bariatric surgery may be more effective for long-term weight loss compared to semaglutide medications like Ozempic. While GLP-1 drugs have transformed weight management, their real-world effectiveness appears lower than in clinical trials. The research highlights the importance of personalized treatment plans, as some patients may benefit more from surgery, while others find success with medications. With rising obesity rates, both approaches are crucial for improving health outcomes and managing chronic diseases.

By Narendra Chaudhary May 29, 2026, 08:12 IST

Introduction to Weight Loss Solutions

Semaglutide-based treatments like Ozempic have revolutionized the weight loss sector, aiding countless individuals in their battle against obesity. However, recent research indicates that bariatric surgery might offer superior long-term weight loss results. A team from New York University (NYU) conducted a comparative analysis of popular GLP-1 weight loss medications, including semaglutide and tirzepatide, against bariatric surgeries such as sleeve gastrectomy and gastric bypass. Their study highlighted significant disparities in weight loss outcomes between these two methods.

Study Findings

What Did the Research Reveal?

The researchers examined health records and matched participants based on factors like age, body mass index (BMI), and blood sugar levels. One cohort had undergone bariatric surgery, while the other was treated with GLP-1 receptor agonist medications. The results were notable: individuals who had metabolic and bariatric surgery experienced an average weight loss of 25.7% over two years, whereas those on GLP-1 medications lost only 5.3% on average. These findings were shared at the American Society for Metabolic and Bariatric Surgery (ASMBS) annual meeting.

Avery Brown, a surgical resident at NYU, pointed out that the actual results for GLP-1 medications seem to be less impressive than those reported in clinical trials. “While clinical trials indicate weight loss of 15% to 21% with GLP-1s, our study suggests that real-world outcomes are significantly lower,” Brown stated.

Reasons for Bariatric Surgery's Effectiveness

Why Is Bariatric Surgery More Effective?

Experts attribute the effectiveness of bariatric surgery to several factors, one being medication adherence. Many patients stop using Ozempic, Wegovy, or other GLP-1 drugs within a year due to side effects, high costs, or challenges in maintaining the regimen. In contrast, bariatric surgery results in permanent alterations to the digestive system, providing a more sustainable weight loss solution for many. Additionally, the study indicated that bariatric surgery improved blood sugar control more effectively than medication alone, which is crucial for individuals with obesity and type 2 diabetes.

Health Benefits of Ozempic

Ozempic Still Offers Important Health Benefits

Despite these findings, researchers do not dismiss the value of semaglutide medications. Originally designed for managing type 2 diabetes, Ozempic has demonstrated benefits beyond weight loss, such as lowering the risk of cardiovascular diseases and potentially reducing certain cancer risks. GLP-1 drugs remain favored over surgery due to their less invasive nature and easier accessibility. For many patients, these medications can still yield significant weight loss and metabolic enhancements.

Considerations for Bariatric Surgery

Surgery Is Not a Quick Fix

Medical professionals warn that bariatric surgery is not a simple solution. Procedures like gastric bypass and sleeve gastrectomy are invasive and permanent, necessitating lifelong lifestyle adjustments. Patients must adhere to strict dietary protocols, engage in regular physical activity, and attend ongoing medical check-ups. The researchers also noted that the study was funded by ASMBS, an organization that advocates for bariatric surgery, which could introduce potential bias.

The Future of Obesity Treatment

Healthcare professionals advocate for personalized obesity treatment plans. Some patients may find success with GLP-1 medications, while others with severe obesity or diabetes might benefit more from metabolic surgery. “As many as 70% of patients may discontinue treatment within a year,” Brown emphasized, highlighting the necessity of long-term adherence for effective weight management. With the global rise in obesity rates, experts believe that both bariatric surgery and GLP-1 medications will continue to be vital in enhancing overall health, mitigating chronic disease risks, and assisting patients in achieving sustainable weight loss.